94. 原発性硬化性胆管炎 Primary sclerosing cholangitis Clinical trials / Disease details

臨床試験数 : 148 / 薬物数 : 118 - (DrugBank : 39) / 標的遺伝子数 : 18 - 標的パスウェイ数 : 141

1 trial found

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT05642468 (ClinicalTrials.gov)	January 23, 2023	23/11/2022	Safety and Tolerability of A3907 in Primary Sclerosing Cholangitis	An Open Label, Phase 2 Study to Evaluate the Effect of A3907on Safety, Tolerability, Pharmacokinetic ...	Primary Sclerosing Cholangitis	Drug: A3907	Albireo	NULL	Recruiting	18 Years	65 Years	All	12	Phase 2	France;Italy;Spain